Senate Bill No. 243, introduced by Senator Reese, amends the existing law regarding sales and use tax exemptions for prescription drugs. The bill specifically clarifies that the exemption applies to the sale of prescription drugs to individuals enrolled in the Louisiana Children's Health Insurance Program under Title XXI of the Social Security Act, as well as those enrolled in any Louisiana Medicaid program under Title XIX of the Social Security Act. The language previously referring to the pharmaceutical vendor program has been deleted, and the bill emphasizes that these provisions are interpretive and do not create new rights or duties.

The bill is set to take effect upon the governor's signature or after the designated time for gubernatorial action if not signed. The amendments aim to ensure clarity in the application of tax exemptions for prescription drugs, reinforcing the state's commitment to supporting healthcare access for eligible individuals.